Aker BioMarine Human Ingredients AS is a leading Norwegian biotechnology company specializing in sustainable marine-based nutritional solutions. Based in Lysaker, Norway, the company is a division of Aker BioMarine ASA, a vertically integrated biotech innovator with a global presence in krill harvesting, product development, and scientific research.
Aker BioMarine Human Ingredients is recognized for pioneering the use of Antarctic krill as a source of omega-3 phospholipids, choline, proteins, and bioactive lipids for human health applications. The company is driven by a strong commitment to sustainability, science-backed innovation, and circular bioeconomy practices.
Core Business
The core products and human nutrition platforms include:
- Superba™ Krill Oil: A pure, phospholipid-bound omega-3 supplement rich in EPA, DHA, and choline
- Lysoveta™: A novel, lysophosphatidylcholine (LPC)-based delivery platform designed for targeted nutrient absorption in the brain and eyes
- PL+ Algae: Phospholipid omega-3 solution derived from algae for plant-based product lines
- Kori™ Krill Oil: A consumer-facing brand launched in the U.S. retail market
- INVI™ Protein: A highly digestible, marine-derived protein powder from krill biomass tailored for sports nutrition and functional food applications
These products are used in dietary supplements, functional foods, and clinical nutrition worldwide.
Specialization and Unique Selling Proposition (USP)
Aker BioMarine Human Ingredients stands apart through:
- Exclusive krill harvesting operations using Eco-Harvesting® technology that minimizes bycatch and preserves marine biodiversity
- Control over the entire value chain—from krill harvesting in Antarctica to final processing in Norway and the U.S.
- Development of phospholipid-based delivery systems, which are scientifically proven to enhance bioavailability and cellular uptake
- Strong clinical and pre-clinical research portfolio, with over 200 peer-reviewed studies supporting the efficacy of its products
The company also invests heavily in biotechnology innovation, including new formats such as protein isolates and phospholipid concentrates.
Financials and Global Presence
Aker BioMarine ASA, the parent company of Aker BioMarine Human Ingredients AS, is listed on the Oslo Stock Exchange (AKBM.OL).
- 2023 Total Revenue: USD 272 million
- Human Ingredients segment accounts for approximately 35–40% of revenue
- Krill biomass processing facility in Houston, Texas (largest of its kind globally)
- Exports to over 60 countries, including the U.S., China, Germany, Australia, and South Korea
- Strategic partnerships with Nestlé Health Science, Swisse, CVS, and leading nutraceutical brands
This global scale ensures supply reliability, localized distribution, and regulatory compliance across major markets.
Shipment and Export Data
According to international trade sources and export documentation:
- Hundreds of metric tons of Superba™ Krill Oil exported annually from Norway and the U.S. to supplement manufacturers and contract formulators
- INVI™ Protein and krill meal also exported to nutrition-focused B2B partners
- Custom formulation and bulk ingredient sales across North America, Asia-Pacific, and the EU
Aker BioMarine maintains full traceability for all shipments, supported by QR-coded blockchain tracking systems.
Target Market
The company targets:
- Nutraceutical manufacturers
- Functional food and beverage companies
- Clinical nutrition developers
- Sports and performance nutrition brands
- Retail and private-label supplement brands
Products are available in both bulk ingredient form and branded finished goods for B2C and B2B channels.
Capabilities
- Owns and operates harvesting vessels (Saga Sea, Antarctic Endurance) equipped with Eco-Harvesting® technology
- Fully integrated manufacturing from Antarctica to Europe and North America
- Proprietary extraction and purification technologies
- Dedicated R&D and application science teams with over 100 scientific collaborations globally
- Support for custom formulations, regulatory dossiers, and scientific substantiation
Certifications and Compliance
Aker BioMarine Human Ingredients maintains the highest global standards:
- MSC Certification (Marine Stewardship Council) – certified sustainable fishery
- GMP, NSF, and FSSC 22000 certified facilities
- Non-GMO Project Verified
- GRAS (Generally Recognized As Safe) status in the U.S. for Superba™ Krill Oil
- EFSA-approved health claims in the EU
Each batch undergoes comprehensive quality testing for heavy metals, oxidative stability, and phospholipid profile.
Customer Feedback and Testimonials
Customers and brand partners report:
- “Superior omega-3 bioavailability and absorption compared to traditional fish oil”
- “Clean, traceable, and sustainable source with strong scientific backing”
- “Flexible support for formulation development and regulatory documentation”
The company has received multiple awards for sustainability and innovation from organizations such as NutraIngredients and Frost & Sullivan.
Major Achievements
- Developed and patented Eco-Harvesting®, revolutionizing krill harvesting practices
- Launched Superba™ Boost and Lysoveta™, new platforms for brain and eye health
- Collaborated with NASA on krill-based nutrients for long-duration space missions
- Included in Dow Jones Sustainability Index for food producers
- Recognized as one of Norway’s leading biotech innovators
Aker BioMarine Human Ingredients AS continues to lead the marine ingredient revolution by combining science, sustainability, and scale to deliver superior health solutions globally.
